NCT00892008View on ClinicalTrials.gov

A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin

CompletedOBSERVATIONAL

Enrollment

2,278

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Neuropathic Pain

Interventions

DRUG

Pregabalin

Pregabalin 75-150 mg BID for at least 2 weeks.

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00892008 - A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin | Biotech Hunter | Biotech Hunter